Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fetter

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|March 15, 1993
Late follow-up of dual-chamber rate-adaptive pacingD G Benditt, L Wilbert, R Hansen, et al.
Journal of Bioenergetics and Biomembranes|April 1, 1993
Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome boJ P Hosler, S Ferguson-Miller, M W Calhoun, et al.
Pacing and Clinical Electrophysiology : PACE|February 17, 1999
Prehospital discharge defibrillation testing in ICD recipients: a prospective study based on cost analysisK G Lurie, D Iskos, J Fetter, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
<i>U2AF1 S34F</i> enhances tumorigenic potential of lung cells by exhibiting synergy with <i>KRAS</i> mutation and altering response to environmental stressCindy E Liang, Eva Hrabeta-Robinson, Amit Behera, et al.
Biochemistry|February 8, 1994
A loop between transmembrane helices IX and X of subunit I of cytochrome c oxidase caps the heme a-heme a3-CuB centerJ P Hosler, J P Shapleigh, M J Tecklenburg, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal CancersAparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid TumorsRyan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|March 15, 1993
Late follow-up of dual-chamber rate-adaptive pacingD G Benditt, L Wilbert, R Hansen, et al.
Journal of Bioenergetics and Biomembranes|April 1, 1993
Insight into the active-site structure and function of cytochrome oxidase by analysis of site-directed mutants of bacterial cytochrome aa3 and cytochrome boJ P Hosler, S Ferguson-Miller, M W Calhoun, et al.
Pacing and Clinical Electrophysiology : PACE|February 17, 1999
Prehospital discharge defibrillation testing in ICD recipients: a prospective study based on cost analysisK G Lurie, D Iskos, J Fetter, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
<i>U2AF1 S34F</i> enhances tumorigenic potential of lung cells by exhibiting synergy with <i>KRAS</i> mutation and altering response to environmental stressCindy E Liang, Eva Hrabeta-Robinson, Amit Behera, et al.
Biochemistry|February 8, 1994
A loop between transmembrane helices IX and X of subunit I of cytochrome c oxidase caps the heme a-heme a3-CuB centerJ P Hosler, J P Shapleigh, M J Tecklenburg, et al.
NPJ Precision Oncology|August 18, 2020
Small cell transformation of <i>ROS1</i> fusion-positive lung cancer resistant to ROS1 inhibitionJessica J Lin, Adam Langenbucher, Pranav Gupta, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2021
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal AdenocarcinomasJennifer Y Wo, Jeffrey W Clark, Christine E Eyler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2020
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal CancersAparna R Parikh, Amikasra Mojtahed, Jaime L Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid TumorsRyan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Pageof 5